We are live on ! Find out more
CCM

Cadence Capital Management Portfolio holdings

AUM $415M
1-Year Est. Return 11.01%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
AUM
$2.09B
AUM Growth
-$289M
Cap. Flow
-$380M
Cap. Flow %
-18.22%
Top 10 Hldgs %
8.31%
Holding
697
New
113
Increased
76
Reduced
358
Closed
150

Top Buys

Rank Stock Value
1
USB icon
US Bancorp
USB
+$11.6M
2
PSX icon
Phillips 66
PSX
+$11.1M
3
MET icon
MetLife
MET
+$10.1M
4
M icon
Macy's
M
+$9.08M
5
ORLY icon
O'Reilly Automotive
ORLY
+$8.37M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.7M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$10.7M
3
GAP
The Gap Inc
GAP
+$8.4M
4
UAL icon
United Airlines
UAL
+$8.14M
5
SKX
Skechers
SKX
+$7.54M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.17%
2 Industrials 14.75%
3 Technology 13.58%
4 Healthcare 12.19%
5 Financials 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HF
126
DELISTED
HFF Inc.
HF
$5.11M 0.24%
137,346
-66,978
-33% -$2.23M
MA icon
127
Mastercard
MA
$506B
$5.1M 0.24%
69,400
-13,500
-16% -$1M
HLX icon
128
Helix Energy Solutions
HLX
$1.4B
$5.09M 0.24%
193,596
-75,378
-28% -$1.79M
CHK
129
DELISTED
Chesapeake Energy Corporation
CHK
$5.08M 0.24%
+864
New +$4.71M
GNW icon
130
Genworth Financial
GNW
$3.76B
$5.07M 0.24%
291,400
-49,010
-14% -$857K
NSC icon
131
Norfolk Southern
NSC
$75.4B
$5.05M 0.24%
48,984
-26,340
-35% -$2.58M
BKNG icon
132
Booking.com
BKNG
$149B
$5M 0.24%
104,000
-21,125
-17% -$1.01M
CME icon
133
CME Group
CME
$96.3B
$4.96M 0.24%
69,956
-6,239
-8% -$439K
AMT icon
134
American Tower
AMT
$80.8B
$4.92M 0.24%
54,625
-20,210
-27% -$1.75M
CPHD
135
DELISTED
Cepheid Inc
CPHD
$4.91M 0.24%
102,351
-12,356
-11% -$560K
PNFP icon
136
Pinnacle Financial Partners Inc
PNFP
$15.9B
$4.9M 0.24%
124,105
-48,535
-28% -$1.74M
BBWI icon
137
Bath & Body Works
BBWI
$4.06B
$4.88M 0.23%
102,909
-27,018
-21% -$1.24M
CODE
138
DELISTED
SPANSION INC, CLASS A COMMON STOCK
CODE
$4.87M 0.23%
+230,925
New +$4.38M
STJ
139
DELISTED
St Jude Medical
STJ
$4.86M 0.23%
70,160
+17,670
+34% +$1.15M
THRM icon
140
Gentherm
THRM
$1.24B
$4.85M 0.23%
109,041
-128,891
-54% -$5.07M
ENTG icon
141
Entegris
ENTG
$18.1B
$4.78M 0.23%
347,786
+12,678
+4% +$150K
SSNC icon
142
SS&C Technologies
SSNC
$18.6B
$4.78M 0.23%
216,210
-84,344
-28% -$1.75M
ASRT
143
DELISTED
Assertio
ASRT
$4.77M 0.23%
5,723
+4,227
+283% +$3.26M
HI
144
DELISTED
Hillenbrand
HI
$4.76M 0.23%
145,973
-57,089
-28% -$1.76M
BFH icon
145
Bread Financial
BFH
$4.37B
$4.75M 0.23%
21,176
-3,132
-13% -$638K
DAN icon
146
Dana Inc
DAN
$2.9B
$4.75M 0.23%
194,457
-75,703
-28% -$1.7M
HNI icon
147
HNI Corp
HNI
$3.24B
$4.74M 0.23%
121,296
-47,237
-28% -$1.73M
IP icon
148
International Paper
IP
$21.6B
$4.73M 0.23%
100,306
-13,531
-12% -$593K
ALXN
149
DELISTED
Alexion Pharmaceuticals
ALXN
$4.69M 0.22%
+30,000
New +$4.74M
KMI icon
150
Kinder Morgan
KMI
$71.7B
$4.67M 0.22%
128,691
-29,663
-19% -$1M

Similar funds

Cadence Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Cadence Capital Management held 697 positions worth $2.09B, down 12% from $2.37B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

Cadence Capital Management withdrew a net $380M in Q2 2014, closing 150 positions and reducing 358 holdings. Its most notable exit was Alnylam Pharmaceuticals, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Industrials and Technology.

Against the trend, Cadence Capital Management opened a new position in US Bancorp worth $12.1M.

  • Cadence Capital Management's largest Q2 2014 buy was US Bancorp: 279,044 shares worth $12.1M.
  • Cadence Capital Management added most to Wynn Resorts in Q2 2014, an estimated $7.23M increase.
  • Cadence Capital Management's biggest Q2 2014 reduction was Apple, cutting an estimated $17.7M.
  • Cadence Capital Management fully exited Alnylam Pharmaceuticals in Q2 2014, selling an estimated $10.7M.
  • Cadence Capital Management's ten largest holdings make up 8.3% of its $2.09B portfolio in Q2 2014.
  • Cadence Capital Management opened 113 new positions and closed 150 in Q2 2014.
  • Cadence Capital Management's portfolio value fell 12% quarter-over-quarter to $2.09B.

Based on Cadence Capital Management's 13F filing for Q2 2014, filed 23 Jul 2014.